Urinary calprotectin, NGAL, and KIM-1 in the differentiation of primarily inflammatory vs. non-inflammatory stable chronic kidney diseases

References

• Fiorentino M, Bolignano D, Tesar V, et al. Renal biopsy in 2015-from epidemiology to evidence-based indications. Am J Nephrol. 2016;43(1):1–19.
   PubMed Web of Science ®Google Scholar
• Olsen S, Mogensen CE. How often is NIDDM complicated with non-diabetic renal disease? An analysis of renal biopsies and the literature. Diabetologia. 1996;39(12):1638–1645.
   PubMed Web of Science ®Google Scholar
• Zhuo L, Ren W, Li W, et al. Evaluation of renal biopsies in type 2 diabetic patients with kidney disease: a clinicopathological study of 216 cases. Int Urol Nephrol. 2013;45(1):173–179.
   PubMed Web of Science ®Google Scholar
• Heller F, Frischmann S, Grunbaum M, et al. Urinary calprotectin and the distinction between prerenal and intrinsic acute kidney injury. Clin J Am Soc Nephrol. 2011;6(10):2347–2355.
   PubMed Web of Science ®Google Scholar
• Seibert FS, Pagonas N, Arndt R, et al. Calprotectin and neutrophil gelatinase-associated lipocalin in the differentiation of pre-renal and intrinsic acute kidney injury. Acta Physiol. 2013;207(4):700–708.
   PubMed Web of Science ®Google Scholar
• de Geus HR, Woo JG, Wang Y, et al. Urinary neutrophil gelatinase-associated lipocalin measured on admission to the intensive care unit accurately discriminates between sustained and transient acute kidney injury in adult critically ill patients. Nephron Extra. 2011;1(1):9–23.
   PubMedGoogle Scholar
• Nickolas TL, Schmidt-Ott KM, Canetta P, et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol. 2012;59(3):246–255.
   PubMed Web of Science ®Google Scholar
• Singer E, Elger A, Elitok S, et al. Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. Kidney Int. 2011;80(4):405–414.
   PubMed Web of Science ®Google Scholar
• Chang CH, Yang CH, Yang HY, et al. Urinary biomarkers improve the diagnosis of intrinsic acute kidney injury in coronary care units. Medicine. 2015;94:e1703.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Fan PC, Kou G, et al. Meta-analysis: urinary calprotectin for discrimination of intrinsic and prerenal acute kidney injury. J Clin Med. 2019;8(1):74.
   Web of Science ®Google Scholar
• Ehrchen JM, Sunderkotter C, Foell D, et al. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol. 2009;86(3):557–566.
   PubMed Web of Science ®Google Scholar
• Schrezenmeier EV, Barasch J, Budde K, et al. Biomarkers in acute kidney injury - pathophysiological basis and clinical performance. Acta Physiol. 2017;219(3):554–572.
   PubMed Web of Science ®Google Scholar
• Goetz DH, Holmes MA, Borregaard N, et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell. 2002;10(5):1033–1043.
   PubMed Web of Science ®Google Scholar
• Flo TH, Smith KD, Sato S, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;432(7019):917–921.
   PubMed Web of Science ®Google Scholar
• Han WK, Bailly V, Abichandani R, et al. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62(1):237–244.
   PubMed Web of Science ®Google Scholar
• Westhoff JH, Fichtner A, Waldherr S, et al. Urinary biomarkers for the differentiation of prerenal and intrinsic pediatric acute kidney injury. Pediatr Nephrol. 2016;31(12):2353–2363.
   PubMed Web of Science ®Google Scholar
• Humphreys BD, Xu F, Sabbisetti V, et al. Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. J Clin Invest. 2013;123(9):4023–4035.
   PubMed Web of Science ®Google Scholar
• Seibert FS, Sitz M, Passfall J, et al. Prognostic value of urinary calprotectin, NGAL and KIM-1 in chronic kidney disease. Kidney Blood Press Res. 2018;43(4):1255–1262.
   PubMed Web of Science ®Google Scholar
• Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.
   Web of Science ®Google Scholar
• Seibert FS, Rosenberger C, Mathia S, et al. Urinary calprotectin differentiates between prerenal and intrinsic acute renal allograft failure. Transplantation. 2017;101(2):387–394.
   PubMed Web of Science ®Google Scholar
• Nickolas TL, O’Rourke MJ, Yang J, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med. 2008;148(11):810–819.
   PubMed Web of Science ®Google Scholar
• Fujiu K, Manabe I, Nagai R. Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J Clin Invest. 2011;121(9):3425–3441.
   PubMed Web of Science ®Google Scholar
• Foell D, Wittkowski H, Vogl T, et al. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol. 2007;81(1):28–37.
   PubMed Web of Science ®Google Scholar
• Dessing MC, Tammaro A, Pulskens WP, et al. The calcium-binding protein complex S100A8/A9 has a crucial role in controlling macrophage-mediated renal repair following ischemia/reperfusion. Kidney Int. 2015;87(1):85–94.
   PubMed Web of Science ®Google Scholar
• Fornoni A, Ijaz A, Tejada T, et al. Role of inflammation in diabetic nephropathy. Curr Diabetes Rev. 2008;4(1):10–17.
   PubMedGoogle Scholar
• Rivero A, Mora C, Muros M, et al. Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clin Sci. 2009;116(6):479–492.
   PubMed Web of Science ®Google Scholar
• Imig JD, Ryan MJ. Immune and inflammatory role in renal disease. Compr Physiol. 2013;3(2):957–976.
   PubMed Web of Science ®Google Scholar
• Wenzel U, Turner JE, Krebs C, et al. Immune mechanisms in arterial hypertension. J Am Soc Nephrol. 2016;27(3):677–686.
   PubMed Web of Science ®Google Scholar
• Kuehn EW, Park KM, Somlo S, et al. Kidney injury molecule-1 expression in murine polycystic kidney disease. Am J Physiol Renal Physiol. 2002;283(6):F1326–36.
   PubMed Web of Science ®Google Scholar
• Meijer E, Boertien WE, Nauta FL, et al. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis. Am J Kidney Dis. 2010;56(5):883–895.
   PubMed Web of Science ®Google Scholar
• Virzi GM, Gastaldon F, Corradi V, et al. [Plasma NGAL and ADPKD progression]. G Ital Nefrol. 2015;32(3):1–8. Italian.
   Google Scholar
• Kawano H, Muto S, Ohmoto Y, et al. Exploring urinary biomarkers in autosomal dominant polycystic kidney disease. Clin Exp Nephrol. 2015;19(5):968–973.
   PubMed Web of Science ®Google Scholar